BCACP EXAM FULLY SOLVED & UPDATED.

FDA Recall Classes Class 1 - situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death Class 2 - situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote Class 3 - situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences Allopurinol dose adjustment for CrCl CrCl 10-20 - 200 mg daily max CrCl less than 10 - 100 mg daily max Anticoagulation for heart valves in the mitral and aortic position (bioprosthetic, mechanical) Bioprosthetic, Aortic - Bioprosthetic, Mitral - Mechanical, Aortic - INR 2-3 Mechanical, Mitral - INR 2.5-3.5 Eliquis (apixaban) - dosing for Afib and VTE AFib 5 mg BID 2.5 mg BID if 2 of 3: (SCr greater than or equal to 1.5, weight less than (or equal to?) 60 kg, age of 80 or older) VTE 10 mg BID for 1 week then 5 mg BID CrCl dose adjustments for spironolactone and eplerenone Spironolactone CrCl 30-50: start at 25 mg QOD or 12.5 mg QD Inducers of CYP3A4 Inhibitors of CYP3A4 Warfarin and alcohol interactions Acute - need to hold warfarin; INR will increase Chronic - need to increase warfarin dose Xarelto (rivaroxaban) dose for Afib, VTE Afib 20 mg daily CrCl 15-50: 15 mg daily VTE 15 mg BID for 21 days then 20 mg QD CrCl 30: do not use Pradaxa (dabigatran) dose for Afib, VTE Afib CrCl 15-30: 75 mg BID VTE 150 mg BID (after 5-10 days of parenteral anticoagulation) CrCl 30: do not use Requirements to be CMR or MTM eligible Chronic Conditions Number of Medications Opioid Conversions morphine - 30 hydrocodone - 30 oxycodone - 20 methadone - 20 oxymorphone - 10 hydromorphone - 7.5